Workflow
中国脑计划
icon
Search documents
全球第二大融资落地!20 亿领跑中国脑机接口赛道
是说芯语· 2026-01-06 23:33
Core Viewpoint - BrainCo, a prominent brain-computer interface (BCI) company in Hangzhou, has gained global attention due to its non-invasive technology and mass production capabilities, positioning itself as a competitor to Neuralink [1][2]. Group 1: Company Overview - Founded in 2015 by Harvard alumnus Han Bicheng, BrainCo is recognized as China's first BCI unicorn and has made significant advancements in non-invasive technology [1][2]. - The company has received major international certifications, including FDA and CE, and ranks among the top in global BCI research and development investments [2]. - BrainCo's flagship product, the BrainRobotics smart bionic hand, has been featured on the cover of TIME magazine's Best Inventions of the Year [2]. Group 2: Technological Innovations - BrainCo's core technology, the super sensor, captures weak brain signals without invasive procedures, enabling applications in rehabilitation for disabled individuals and treatment for conditions like autism and Alzheimer's [4]. - The company has successfully launched products such as the smart bionic hand and bionic leg, which allow users to perform complex movements, showcasing the practical impact of BCI technology [4]. Group 3: Market Position and Financing - BrainCo recently completed a financing round of approximately 2 billion RMB, making it the second-largest financing in the global BCI sector after Neuralink [5]. - The investment consortium includes renowned firms like IDG and strategic partners such as Lens Technology, indicating strong market confidence in BrainCo's potential [5]. - The company is preparing for an IPO, with plans to list in Hong Kong or on the STAR Market, reflecting its growth trajectory and market ambitions [5]. Group 4: Future Prospects - Han Bicheng envisions BCI technology transforming everyday life, with plans to assist 1 million disabled individuals and 10 million patients with brain-related conditions over the next 5 to 10 years [7]. - The demand for BCI solutions is significant, given that over 24 million people in China live with physical disabilities, alongside rising cases of brain diseases [7]. - BrainCo's growth is supported by Hangzhou's favorable innovation environment and government funding, which has been crucial for its development [8].
马斯克才做了7例,中国却悄悄完成30例!他说脑病研究已迈入AI时代
Sou Hu Cai Jing· 2025-11-14 08:57
Group 1 - The probability of developing dementia increases significantly with age, from 6.3%-6.5% for those aged 65 to 52% for those aged 90, but this probability can be altered through interventions [1] - Brain-computer interface (BCI) technology offers new hope for the prevention and control of Alzheimer's disease and other brain disorders, as highlighted by academic experts [1][4] - Domestic research in brain-computer interfaces is progressing steadily, with clinical trials showing promising results, including patients regaining the ability to interact with the physical world [3][4] Group 2 - The establishment of the brain-computer interface clinical and translational center at Shandong First Medical University aims to apply existing BCI technologies in clinical settings, develop new technologies, and collaborate with enterprises for device commercialization [5] - Over 30 clinical trials of brain-computer interfaces have been completed in China, demonstrating significant advancements in treating conditions like Parkinson's disease and improving the quality of life for dementia patients [4][5] - The integration of artificial intelligence and brain-computer interface technology is expected to revolutionize human-device interaction, moving beyond traditional methods [3][5] Group 3 - Depression is a prevalent mental health issue, with a lifetime prevalence rate of 6.9% in China, highlighting the need for increased awareness and treatment options [6][7] - The lack of public understanding regarding mental health issues has been a long-standing challenge, necessitating ongoing education and outreach efforts [6][7] - The establishment of specialized sleep medicine departments and the development of clinical guidelines reflect a growing recognition of the importance of sleep health in overall well-being [8][9]